Moving Forward

FDA Approves Two New Medications to Treat Acute Migraine Attacks — Guest Blogger Chicago Headache Center & Research Institute

Looking for the Light

In the last six weeks two new oral medications have become available for the acute treatment of migraine. Reyvow (lasmitidan) was approved by the Food and Drug Aministration (FDA) October 11, 2019, but it has only recently been made available to prescribe. Ubrelvy (ubrogepant) was approved by FDA December 23, 2019, and is also now […]

FDA Approves Two New Medications to Treat Acute Migraine Attacks — Chicago Headache Center & Research Institute

2 thoughts on “FDA Approves Two New Medications to Treat Acute Migraine Attacks — Guest Blogger Chicago Headache Center & Research Institute”

Thanks for stopping by, I look forward to seeing you again soon. :)